Effects of Inspiratory Muscle and Endurance Training in Heart Failure Patients With Pacemaker

Sponsor
Gazi University (Other)
Overall Status
Completed
CT.gov ID
NCT03501355
Collaborator
(none)
30
1
2
17.3
1.7

Study Details

Study Description

Brief Summary

It is well-known that not only peripheral muscles, but also respiratory muscles muscle weakness and deconditioning play an important role in low exercise capacity of patients with Heart Failure (HF). Exercise training has been shown to improve exercise tolerance and quality of life in patients with heart disease. However, hearth failure patients with pacemaker such as implantable cardioverter defibrillators (ICDs), cardiac resynchronization pacemakers or defibrillators (CRT-P or CRT-D) have additional specific issues when performing exercise. No study investigated the effects of different inspiratory muscle training protocols. For this reason, we aimed to investigate the effects of inspiratory muscle training on outcomes in hearth failure patients with pacemaker

Condition or Disease Intervention/Treatment Phase
  • Device: Inspiratory muscle strength training
  • Device: Inspiratory muscle endurance training
N/A

Detailed Description

Heart failure patients with pacemaker will be included. Primary outcome measurement is respiratory muscle strength, secondary outcomes are functional exercise capacity, peripheral muscle strength, pulmonary functions, maximal exercise capacity, fatigue, quality of life, depression, physical activity.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Effects of Inspiratory Muscle and Endurance Training on Exercise Capacity, Respiratory Muscle Strength and Endurance and Quality of Life in Heart Failure Patients With Pacemaker
Actual Study Start Date :
Apr 20, 2018
Actual Primary Completion Date :
May 30, 2019
Actual Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Strength training group

Intervention:Inspiratory muscle strength training group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device

Device: Inspiratory muscle strength training
Treatment group will receive inspiratory muscle training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 50% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 50% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.

Active Comparator: Endurance training group

Intervention: Inspiratory muscle endurance training group received inspiratory muscle endurance training (IMT) using POWERbreathe Classic threshold loading device

Device: Inspiratory muscle endurance training
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.

Outcome Measures

Primary Outcome Measures

  1. Maximal Exercise capacity [First day]

    Incremental Shuttle Walk Test

Secondary Outcome Measures

  1. Inspiratory and expiratory muscle strength (MIP, MEP) [First day]

    Mouth pressure device

  2. Peripheral muscle strength [First day]

    Hand held dynamometer

  3. Pulmonary functions [First day]

    Spirometry

  4. Fatigue [Second day]

    Fatigue Severity Scale (FSS) (Turkish version of scale) Patient choose a number from 1 to 7 that indicates how much the patient agrees with each statement, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 4 or higher generally indicates severe fatigue

  5. Quality of life [Second day]

    Short Form (SF-36) Health Survey (Turkish version of scale) The SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). For each dimension item scores are coded, summed, and transformed on to a scale from 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).

  6. Depression [Second day]

    Montgomery Asberg Depression Rating Scale (MADRS) (Turkish version of scale) This assessment tool contains 10 items with a score from 0 to 6, thus the maximum score is 60. A higher score indicates a more severe depression.

  7. Physical activity [Second day]

    International Physical Activity Questionnaire (IPAQ) - Short Form (Turkish version of scale ) This questionnaire assesses, in minutes, the physical activity performed by the volunteers during the period of one week. The IPAQ considered all activities carried out by the volunteer (e.g. leisure, sport, exercise, and activities at home or in the garden). According to the responses, the volunteer is considered very active, active, irregularly active or sedentary, according to the intensity and time of the exercises practiced over the last week.

  8. Health-related quality of life [Second day]

    Minnesota Living with Heart Failure Questionnaire (MLHFQ) (Turkish version of scale) 21 items rated on six-point Likert scales, representing different degrees of impact of HF on Heart Related Quality of Life (HRQoL), from 0 (none) to 5 (very much). It provides a total score (range 0-105, from best to worst HRQoL), as well as scores for two dimensions, physical (8 items, range 0-40) and emotional (5 items, range 0-25).

  9. Cognitive function [First day]

    Mini mental state examination (MMSE)(Turkish version of scale ) The scale has a maximum score of 30 points. The questions have been grouped into seven categories, each rationally representing a different cognitive domain or function: Orientation to time (5 points); Orientation to place (5 points); Registration of three words (3 points); Attention and Calculation (5 points); Recall of three words (3 points); Language (8 points) and Visual Construction (1 point). The severity of cognitive impairment is classified as normal (30-27) mild cognitive impairment (26-20); moderate cognitive impairment (19-10); and severe cognitive impairment(< 10).

  10. Functional exercise capacity [Second day]

    6 minute walking test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Heart failure patients with Pacemaker who are clinically stable

  • After 12 weeks of pacemaker implantation

  • No change in medications over one month

Exclusion Criteria:

Patients with

  • Severe cognitive disorders

  • Pulmonary, neurological and orthopedic diseases

  • Pregnant and lactating patients

  • Acute infection or exacerbation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mustafa Kemal University Hatay Turkey 31135

Sponsors and Collaborators

  • Gazi University

Investigators

  • Study Director: Meral Boşnak-Güçlü, PhD, Gazi University Faculty of Health Science Department of Physical Therapy and Rehabilitation
  • Study Chair: Nihan Katayıfçı, MSc, Mustafa Kemal University School of Physical Therapy and Rehabilitation
  • Principal Investigator: Fatih Şen, PhD, Mustafa Kemal University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Meral Boşnak Güçlü, Assoc. Prof, Gazi University
ClinicalTrials.gov Identifier:
NCT03501355
Other Study ID Numbers:
  • Gazi University 7
First Posted:
Apr 18, 2018
Last Update Posted:
Jul 6, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Meral Boşnak Güçlü, Assoc. Prof, Gazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2021